Hepatocyte growth factor inhibits hypoxia/reoxygenation-induced activation of xanthine oxidase in endothelial cells through the JAK2 signaling pathway
Zhang, Y.Q., Hu, S.Y., Chen, Y.D., Guo, M.Z., & Wang, S.
You May Also Be Interested In:
Looking Back at WoTS 2026: Innovation, Connections and a Great Week in Utrecht
Read more
Introducing Baker Rx: Proven Engineering. Optimized for Pharmacy.
Read more
BSC Technical Training | Baker Company | Oct 19-21, 2026
Read more
Baker Flow Werkbanken – Kwaliteit die blijft presteren
Read more
Baker Hosts International Dealer Meeting & Factory Visit in Bridgend, Wales
Read more
First EuroFlow EF-N Installed in the U.S. at University of Miami Sylvester Comprehensive Cancer Center
Read more
Cold Lab Services and The Baker Company: A Strong New Partnership
Read more
Lifecycle Support Update 2026: Baker and/or CleanAir Benelux Flowbenches
Read more
The Baker Company certified ISO 14001:2015 for 2026
Read more
Stay informed
Subscribe to the Baker Company newsletter for the latest articles, product updates, and event announcements.
Stay up to date